• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
Alumni

The Business of Medical Innovation

  Dr. Maria Berkmann
 

Dr. Maria Berkman holds the Vascular Graft Solutions device, which is the first commercial product in Broadview’s portfolio.
Photo: Courtesy of Dr. Maria Berkman

Maria Berkman, MD ’09, MBA, is a director at Broadview Ventures in Boston, Massachusetts, the venture-investment arm of the Leducq Foundation. Broadview’s mission is to accelerate the development of promising technology in cardiovascular and neurovascular diseases through targeted investments in, and support of, early-stage ventures. At Broadview, Dr. Berkman shares responsibility for day-to- day operations, including the identification and screening of new opportunities, diligence, negotiation of deals and portfolio-company board involvement. Prior to joining Broadview, Dr. Berkman was a management consultant with Monitor Group (now Monitor Deloitte), where she specialized in life sciences with a focus on corporate strategy, franchise and asset-level commercialization, and competitive strategic planning. She also completed the Transitional Year Internship Program within the Partners HealthCare System in Boston.

I was one of seven students from the class of 2009 enrolled in the MD/MBA joint-degree program at UCLA. Of those seven, I am the only one who has pursued a career outside of medicine. Following an intern year in Boston, I joined Monitor Group, a management-consulting firm focused on strategy projects for Fortune 500 biopharmaceutical companies. Consulting is like residency for the business world, and after two years of ‘training,’ I was fortunate enough to join Broadview Ventures, a venture-capital firm entirely funded by the Leducq Foundation, a philanthropic organization that focuses on cardiovascular disease as its mission.

Because we invest in very early-stage companies, the proposals I review are typically in the preclinical and/or translational-research phase, making a substantial part of our diligence scientific in nature. In diligence, I spend roughly equal amounts of time leveraging my medical knowledge and my business degree. In addition to ensuring that the companies in which we invest have outstanding science, data and intellectual property as a foundation, we also thoroughly evaluate their business plans, management teams and financial projections — a sound investment has to have those components.

One of my first investments at Broadview was Zumbro Discovery, founded by John Burnett, MD, of the Mayo Clinic, one of the leaders of the natriuretic peptide field. Zumbro had just completed its large animal studies, and with Broadview’s investment, it is now completing enrollment of a Phase 1b trial in resistant hypertension. In an equally exciting milestone, thanks to Broadview’s investment, Vascular Graft Solutions (VGS) has been able to bring an external-support device for vein grafts in coronary-artery-bypass grafting to the market in Europe. VGS is the first of Broadview’s portfolio companies to commercialize. Seeing our portfolio’s researchers and entrepreneurs take products from concept to patient is exciting and gratifying and one small step toward addressing numerous unmet needs in the cardiovascular space.


Previous
In Her Own Words: Lynn L. Huang, MD ’07
Next
Tribute to a Mentor and Friend


YOU ARE VIEWING

Fall 2015

Fall 2015
E-Brochure
Printable PDF
IN THIS ISSUE
  • We Are the World
  • Camp Leg Power Propels Kids with Cerebral Palsy Forward
  • Portable Finger Probe Measures Liver Function in Potential Donors
  • Stem-cell Therapy Holds Promise for Eliminating HIV Infection
  • REM Sleep Helps Brain Capture Snapshots of Dream Images
  • Germline Cells Shown to be Vulnerable during Pregnancy
  • New Study Opens Window on Mutations in Genetic Architecture of Schizophrenics
  • How Molecular Rules Govern Autoimmune Disorders
  • Predicting Response to Treatment for Obsessive-Compulsive Disorder
  • Why Children’s Recovery Times Vary after Traumatic Brain Injury
  • Potentially Effective Treatment for Meth Addiction
  • Protein that Helps Suppress Cancer Fades as We Age
  • Patient First to Bridge from Experimental Total Artificial Heart to Transplant
  • UCLA Community Based Learning: Bridging the Transition from Youth to Adulthood
  • Get Social
  • The End of Darkness
  • Medicine 2.0
  • White Knight
  • Awards, Honors & Grants
  • In Memoriam
  • Postcard from Malawi
  • In Her Own Words: Lynn L. Huang, MD ’07
  • The Business of Medical Innovation
  • Tribute to a Mentor and Friend
  • Kaleidoscope Ball Highlights Artistic Variety
  • Landmark Gift Paves the Way for Breakthroughs
  • The UCLA Today’s and Tomorrow’s Children’s Fund Names New Awardees
  • Golden Portal Fundraiser Joins Movies, Medicine and Technology
  • Widening the Circle of Giving
  • UCLA Names Landmark New Medical-Education Building Geffen Hall
  • Gifts
  • In Memoriam
  • Good Afternoon, Mrs. Gates
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth